Navigation Links
Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
Date:10/12/2009

ROCKVILLE, Md., Oct. 12 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults. Fanapt((TM)) is a mixed dopamine D2 / serotonin 5HT2A receptor antagonist. The U.S. anti-psychotic market is approximately $14 billion.

Under the terms of the agreement, which amended and restated a prior agreement among the parties, Novartis will have exclusive commercialization rights to Fanapt(TM) for the U.S. and Canada. Novartis will be responsible for the further clinical development activities in these territories, including the development and commercialization of a long-acting injectable (or depot) formulation of Fanapt(TM). Vanda will retain rights to commercialize Fanapt(TM) oral and depot formulations outside the U.S. and Canada. At Novartis' option, the parties will enter into good faith discussions relating to an agreement for the co-commercialization of Fanapt(TM) outside of the U.S. and Canada or, alternatively, Novartis will receive a royalty on net sales.

Under the agreement, Vanda will receive an upfront payment of $200 million and will be eligible for additional payments totaling up to $265 million upon the achievement of certain development and commercial milestones for Fanapt(TM) in the U.S. and Canada. Vanda will also receive royalties on the U.S. and Canadian net sales of Fanapt(TM). The consummation of the transaction is subject to the receipt of customary regulatory approvals, which are expected by the end of 2009.

"I am very excited about our agreement with Novartis, as we now have one
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Vanda Pharmaceuticals Provides Update on Iloperidone
4. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
5. Vanda Presents Phase III Iloperidone Efficacy Data
6. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
7. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
8. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
9. Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives
10. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
11. Onyx Pharmaceuticals to Acquire Proteolix, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... DALLAS , July 3, 2015 ... report "Cardiac Monitoring & Cardiac Rhythm Management Market ... Output Monitoring, Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber ... published by MarketsandMarkets, the global Cardiac Monitoring (CM) ... poised to reach $26,646.5 Million by 2020 from ...
(Date:7/3/2015)... Redwood Pharma AB has entered into a ... both the US and China , ... hydrogel technology in its lead chronic Dry Eye therapeutic ... technology offers many unique competitive benefits. At lower temperatures, ... low concentrations of polymer the system can be transitioned ...
(Date:7/2/2015)... , July 2, 2015 ResMed Inc. (NYSE: ... fourth quarter and fiscal year ended June 30, 2015 results ... Exchange market close. A press release with ResMed,s results will ... company will host a webcast to discuss operating results and ... begin at 1:30 p.m. US Pacific Time and the live ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... Sept. 1 There has been recent,concern that ... Montelukast is a Food and Drug Administration (FDA) ... than a decade for the treatment of,asthma and ... the,American Lung Association has found no evidence of ...
... CMS, Inc., an Elekta Company and,worldwide ... management,solutions, today announced that three sites have ... Modulated,Radiotherapy (IMRT) treatment planning system. Allegheny General ... Rotterdam,Netherlands, and Froedtert Memorial Lutheran Hospital in ...
Cached Medicine Technology:American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast 2American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast 3CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System 2
(Date:7/3/2015)... ... ... Talcum powder attorneys representing clients in national lawsuits announce the launch of ... Just as the previous version did, the new website will serve as a public ... cancer warning information. The site is routinely updated with news articles on talcum powder ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ... the latest and coolest technology products available to consumers. Amanda Forstrom, a technology expert ... selfie sticks are great for documenting memories. , Almost every smartphone has an incredibly ...
(Date:7/3/2015)... ... 2015 , ... The Celebrity Dresses is currently running a promotion through July ... will have the opportunity to get 10% discount on orders that are over $100. ... have to use coupon codes or remember redemption codes. , There is a ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to ... the 19th sweetFrog store located in the Lone Star State. The premium frozen yogurt ... in 2014. , The store, which opened July 1 at Duke’s Travel Plaza, is ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker ... at the University of Minnesota, they knew it would save the university energy ... an award-winning choice: the total energy savings after installation was an impressive 89 ...
Breaking Medicine News(10 mins):Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2
... February 16, 2011 An article published in a forthcoming ... of the first to provide evidence of the effectiveness ... suffering from posttraumatic stress disorder (PTSD). The study shows ... in PTSD symptoms after an average of seven treatment ...
... Sciences, National Academy of Engineering, Institute of Medicine, and National ... annual meeting of the American Association for the Advancement of ... Washington, D.C. Tribute to Stephen H. ... East (Renaissance Downtown), Stephen Schneider, a renowned climate scientist at ...
... 16, 2011 − One of the tough challenges a parent ... parent the surviving children, and the task begins immediately, according ... moment their child dies, parents are faced with the two ... a child and the ongoing, daily demands from their surviving ...
... HealthDay Reporter , TUESDAY, Feb. 15 (HealthDay News) ... when they,re first tested may not need to be screened ... new study suggests. Dutch researchers presenting the findings ... few men with a PSA below 3.0 ng/ml were likely ...
... newly diagnosed with Alzheimer,s disease or other dementias, and ... how to plan for the patient,s progressive loss of ... by a physician at the San Francisco VA Medical ... "When a patient is diagnosed with Alzheimer,s disease or ...
... -- Psychotherapy triggers changes in the brains of people ... Medication and psychotherapy are used to treat people with ... overwhelming fear of interacting with others and of being ... the neurological effects of psychotherapy (talk therapy) than on ...
Cached Medicine News:Health News:Innovative virtual reality exposure therapy shows promise for returning troops 2Health News:Media advisory -- events at AAAS 2Health News:Media advisory -- events at AAAS 3Health News:Media advisory -- events at AAAS 4Health News:Parenting after the death of a child a difficult balancing act: York U study 2Health News:PSA Test Cut-off Could Signal Low-Risk Prostate Cancer 2Health News:PSA Test Cut-off Could Signal Low-Risk Prostate Cancer 3Health News:Financial planning a key but neglected component of Alzheimer's care, say researchers 2Health News:'Talk Therapy' Can Alter Brain Activity, Research Shows 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: